Effects of a short-term alirocumab administration on the aortic stiffness: preliminary results.
作者信息
Mauro Feola, Cinzia Ferreri, Arianna Rossi, Marzia Testa, Gaetano Ruocco, Tassone Francesco
机构信息
Cardiology Division Ospedale Regina Montis Regalis Mondovi', Italy.
School of Geriatry Università degli Studi di Torino, Torino, Italy.
出版信息
J Geriatr Cardiol. 2019 Oct;16(10):782-784. doi: 10.11909/j.issn.1671-5411.2019.10.001.
Abstract
摘要
相似文献
1
Effects of a short-term alirocumab administration on the aortic stiffness: preliminary results.
J Geriatr Cardiol. 2019 Oct;16(10):782-784. doi: 10.11909/j.issn.1671-5411.2019.10.001.
2
Volume status and arterial blood pressures are associated with arterial stiffness in hemodialysis patients.容量状态和动脉血压与血液透析患者的动脉僵硬度相关。
Int J Artif Organs. 2018 Jul;41(7):378-384. doi: 10.1177/0391398818778212. Epub 2018 May 28.
3
Noninvasive Estimation of Aortic Stiffness Through Different Approaches.通过不同方法无创性估测主动脉僵硬度。
Hypertension. 2019 Jul;74(1):117-129. doi: 10.1161/HYPERTENSIONAHA.119.12853. Epub 2019 May 28.
4
Differential impact of local and regional aortic stiffness on left ventricular remodeling: a cardiovascular magnetic resonance study.局部和区域性主动脉僵硬度对左心室重构的影响差异：一项心血管磁共振研究。
J Hypertens. 2018 Mar;36(3):552-559. doi: 10.1097/HJH.0000000000001597.
5
Aortic-brachial stiffness mismatch and mortality in dialysis population.透析人群中主动脉-肱动脉僵硬度不匹配与死亡率。
Hypertension. 2015 Feb;65(2):378-84. doi: 10.1161/HYPERTENSIONAHA.114.04587. Epub 2014 Dec 1.
6
Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus.脂蛋白（a）作为老年2型糖尿病患者动脉僵硬度的一个决定因素。
Clin Chim Acta. 2006 Nov;373(1-2):127-31. doi: 10.1016/j.cca.2006.05.018. Epub 2006 May 17.
7
Quantification of aortic stiffness using magnetic resonance elastography: Measurement reproducibility, pulse wave velocity comparison, changes over cardiac cycle, and relationship with age.使用磁共振弹性成像技术定量评估主动脉僵硬度：测量的可重复性、脉搏波速度比较、心动周期变化以及与年龄的关系。
Magn Reson Med. 2016 May;75(5):1920-6. doi: 10.1002/mrm.25719. Epub 2015 Jun 12.
8
Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.2型糖尿病患者中骨硬化蛋白和Dickkopf-1与主动脉僵硬度的相关性：一项前瞻性横断面研究。
Diab Vasc Dis Res. 2019 May;16(3):281-288. doi: 10.1177/1479164118816661. Epub 2018 Dec 14.
9
Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension.代谢综合征与未经治疗的原发性高血压患者的主动脉僵硬度有关。
Hypertension. 2005 Jun;45(6):1078-82. doi: 10.1161/01.HYP.0000165313.84007.7d. Epub 2005 May 2.
10
Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.赖诺普利和阿替洛尔对血液透析患者主动脉僵硬度的影响。
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):639-45. doi: 10.2215/CJN.09981014. Epub 2015 Mar 17.
引用本文的文献
1
An Update on the Role of Arterial Stiffness in Heart Failure and the Treatment of Dyslipidemia.动脉僵硬度在心力衰竭及血脂异常治疗中的作用进展
J Clin Med. 2023 May 4;12(9):3270. doi: 10.3390/jcm12093270.
本文引用的文献
1
The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association.心室-动脉偶联在心脏疾病和心力衰竭中的作用：评估、临床意义和治疗干预。欧洲心脏病学会工作组主动脉及外周血管疾病、欧洲心血管影像协会和心力衰竭协会的共识文件。
Eur J Heart Fail. 2019 Apr;21(4):402-424. doi: 10.1002/ejhf.1436. Epub 2019 Mar 12.
2
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.依洛尤单抗与急性冠脉综合征后的心血管结局。
N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.
3
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
4
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes.使用前蛋白转化酶枯草溶菌素/九型凯欣（PCSK9）抑制剂来减轻心血管炎症并改善预后。
Curr Med Chem. 2017;24(14):1403-1416. doi: 10.2174/0929867324666170303123734.
5
Effects of statin therapy on arterial stiffness: A systematic review and meta-analysis of randomized controlled trial.他汀类药物治疗对动脉僵硬度的影响：一项随机对照试验的系统评价和荟萃分析
Int J Cardiol. 2017 Jan 15;227:338-341. doi: 10.1016/j.ijcard.2016.11.073. Epub 2016 Nov 9.
6
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.阿利西尤单抗降低血脂和心血管事件的疗效和安全性。
N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15.
7
Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin.阿利西尤单抗可抑制动脉粥样硬化，改善斑块形态，并增强他汀类药物的疗效。
J Lipid Res. 2014 Oct;55(10):2103-12. doi: 10.1194/jlr.M051326. Epub 2014 Aug 19.
8
Evaluating interventions to reduce central aortic pressure, arterial stiffness and morbidity--mortality.评估干预措施以降低中心主动脉压、动脉僵硬和发病率-死亡率。
J Hypertens. 2012 Jun;30 Suppl:S13-8. doi: 10.1097/HJH.0b013e328353e523.
9
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.动脉僵硬度预测心血管事件和全因死亡率：系统评价和荟萃分析。
J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27. doi: 10.1016/j.jacc.2009.10.061.
10
Expert consensus document on arterial stiffness: methodological issues and clinical applications.动脉僵硬度专家共识文件：方法学问题与临床应用
Eur Heart J. 2006 Nov;27(21):2588-605. doi: 10.1093/eurheartj/ehl254. Epub 2006 Sep 25.
Zotero 插件